Unique Testing Advantage LKC's RETeval device is FDA cleared for non dilated ERG VEP testing, enabling fast, comfortable retinal assessments with color coded reports. This differentiates the product for ophthalmology and optometry clinics seeking efficient data to guide follow up and progression risk decisions.

Strategic Backing AMETEK's acquisition positions LKC to scale through broader distribution, service networks, and capital. This creates cross sell opportunities with other AMETEK medical devices and potential bundled financing for clinics investing in retinal testing.

DR Education Push DR management is a focus in optometry and ophthalmology, with guideline updates driving best practices. This creates demand for training, clinical protocols, and RETeval data tools to support DR management and patient education.

Data Integration RETeval reports can be integrated with EMR and EHR systems and practice management workflows to streamline documentation, referrals, and follow up. Opportunities exist with EMR vendors and clinic IT teams seeking interoperable retinal testing data.

Mid Market Growth Target mid size ophthalmology and optometry practices as well as clinic networks that can justify investment for improved diagnostic capability and patient engagement. Focus on building a scalable direct sales motion and strategic partnerships with networks and distributors.